Trial Information
DNA Microarray Analysis of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsies to Discriminate Benign From Malignant Pancreatic Lesions
Inclusion Criteria:
- Adults aged 18 or older who are able to give informed consent who present for an
endoscopic ultrasound to evaluate a pancreas mass or cyst or for suspicion of cancer.
Exclusion Criteria:
- Unable to give informed consent, pregnant or nursing, contraindication to endoscopic
ultrasound, no mass or cyst found on ultrasound
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Gene expression profile is 95% accurate in diagnosis of malignancy
Outcome Time Frame:
after enrollment of 50 patients
Safety Issue:
No
Principal Investigator
Sarah Rodriguez, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Oregon Health and Science University
Authority:
United States: Institutional Review Board
Study ID:
IRB4191
NCT ID:
NCT00680420
Start Date:
June 2008
Completion Date:
June 2011
Related Keywords:
- Pancreas Cancer
- pancreas cancer
- pancreas cyst
- DNA microarray
- Pancreatic Neoplasms
Name | Location |
Oregon Health and Science University |
Portland, Oregon 97201 |